H1 Blog

JULY 24, 2023

P&T committees at hospitals, government organizations and insurers decide which drugs will make their formulary lists. In a typical value-based contract , the manufacturer and the payer take on a level of risk; if the drug does not perform as expected, the manufacturer likely reimburses the payer for a portion or all the costs.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Treatment Pharmacy 52

H1 Blog

DECEMBER 11, 2024

Drug Pricing, Global Diversity Strategies, & Emerging AI Applications Each year, we compile our predictions to provide life sciences, pharmaceutical, and healthcare organizations with a comprehensive look at emerging industry trends and dynamics to help them prepare for the year ahead.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

H1 Blog

JUNE 8, 2023

In this blog post, we’ll explore how early diversity in HCP engagement can drive better outcomes and equity in drug development. The drug development process is known to be often expensive, lengthy, and full of trial and error before finding success.

Drug Development 52

Drug Development Science Pharmaceutical Companies Production 52

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

H1 Blog

MARCH 28, 2023

This includes enrollment in Medicare Advantage plans with and without prescription drug coverage. This includes enrollment in stand-alone prescription drug plans as well as Medicare Advantage plans that offer prescription drug coverage. To learn more about Carevoyance, H1’s Claims Intelligence Solution, request a demo.

Production 52

Production Marketing Treatment Hospitals 52

sptlabtech

FEBRUARY 13, 2023

See our expanded portfolio at Booth 1823 We had a fantastic number of customers visit us at Booth 1823 to find out more about our full portfolio – from genomics and drug discovery to automated sample management. Underpinned by powerful, intuitive software, firefly unlocks the potential of automation for all to accelerate genomic research.

DNA 52

DNA Laboratories Production Science 52

H1 Blog

NOVEMBER 29, 2023

Breaking the Barriers: How Inaccurate Trial Records Are Delaying Drug Development and Limiting Diverse Patient Populations In an October 2023 report , BMC Medicine completed a follow-up on a 10-year effort to understand, report on and track data sharing challenges with big pharma, specifically for clinical trials.

Clinical Trials 59

Clinical Trials Trials Drug Development Treatment 59

Practical Cheminformatics

MAY 2, 2023

While machine learning (ML) models have become integral to many drug discovery efforts, most of these models are "black boxes" that don't explain their predictions. I've assembled a demo Jupyter notebook available on GitHub for those who like code. There are several reasons we would like to be able to explain a prediction.

Drugs 52

Drugs 52

H1 Blog

SEPTEMBER 26, 2023

Food and Drug Administration authorized and approved the new shot. A recent McKinsey analysis of drugs and vaccines developed since 2000 shows that it takes nearly ten years to go from clinical testing to approval. Request a demo of Trial Landscape. It comes just a day after the U.S.

Trials 59

Trials Clinical Trials International Regulations 59

Vial

JUNE 24, 2024

Contract research organizations (CROs) and pharmaceutical companies can leverage these cutting-edge technologies to streamline clinical trials and introduce automation in drug discovery. Connect with a team member to learn more or request a demo of our technology!

Clinical Trials 52

Clinical Trials Trials Clinical Research Treatment 52

Practical Cheminformatics

JUNE 22, 2020

As a test, I used t-SNE to map the chemical space for a set of 1,495 drugs from the ChEMBL database. I performed a similar comparison on the same ChEMBL drug dataset with a CPU implementation of UMAP and the GPU implementation in RAPIDS. A couple of comments on that post suggested UMAP as an alternative to t-SNE.

Packaging 52

Packaging Science Drugs 52

The Strateos Blog: Drug Discovery

OCTOBER 27, 2022

Live demos of the LodeStar software allowed scientists to build experiments in Amsterdam during the conference and have them executed virtually in real time at our labs in California. Strateos had the opportunity to connect with industry peers at our booth during this year’s congress in Amsterdam.

Science 52

Science Laboratories Compliance Engineering 52

Codon

JUNE 26, 2023

A live demo is available online, but “it chews through OpenAI credits,” Patel says. There’s a live demo available online. “Right now, it can only make one protein at a time,” Gershon says, simply because the demo has limited compute resources. “Every query is like $2.” A Mycoplasma cell.

DNA 52

DNA Therapies Engineering Clinical Trials 52

Codon

JUNE 26, 2023

A live demo is available online, but “it chews through OpenAI credits,” Patel says. There’s a live demo available online. “Right now, it can only make one protein at a time,” Gershon says, simply because the demo has limited compute resources. “Every query is like $2.” A Mycoplasma cell.

DNA 52

DNA Therapies Engineering Clinical Trials 52

Codon

MAY 30, 2023

Read *MISATO - Machine learning dataset of protein-ligand complexes for structure-based drug discovery. Read | Read A tablet version of semaglutide, the weight loss drug, helped people shed 15.1% They make a drug, called VMX-C001, that is a recombinant form of blood clotting factor X protein. The demos are this Sunday, June 4th!

DNA 52

DNA RNA Engineering Vaccine 52

Codon

MAY 30, 2023

Read *MISATO - Machine learning dataset of protein-ligand complexes for structure-based drug discovery. Read | Read A tablet version of semaglutide, the weight loss drug, helped people shed 15.1% They make a drug, called VMX-C001, that is a recombinant form of blood clotting factor X protein. The demos are this Sunday, June 4th!

DNA 52

DNA RNA Engineering Vaccine 52

Agency IQ

MAY 31, 2024

CHMP opinions from May are still pending; once these are released, AgencyIQ will update this table.

Regulations 40

Regulations Production Compliance Pharmaceuticals 40

Agency IQ

DECEMBER 1, 2023

The European Commission also plans to create a Critical Medicines Alliance for a more coordinated effort in managing drug shortages within the E.U. We are expecting to see the release of an E.U. This effort will most likely be set up in early Q1 of 2024.

Regulations 40

Regulations Clinical Trials Production Biosimilars 40

Codon

AUGUST 28, 2024

Entering the DNA sequence into the SecureDNA demo also outputs variola virus, much like BLAST, but it happens in a fraction of the time. Two screening tools that use k-mer lookup, FAST-NA and SecureDNA, were developed with cryptographers and designed to safeguard sequence information while remaining rapid and sensitive.

DNA 93

DNA Bioinformatics Virus Government 93

Agency IQ

MARCH 29, 2024

EPA is considering options to partially restore the exemption, particularly regarding pediculicide products.

Regulations 40

Regulations Compliance Production Government 40

Advarra

DECEMBER 12, 2024

The system should also include the ability to capture regulations applied to a research project such as Common Rule, Food and Drug Administration (FDA) regulations, and expedited and exempt regulations. Demo requests: Schedule demonstrations with each potential vendor for a more hands-on experience.

Compliance 52

Compliance Regulations Research Clinical Trials 52